249 related articles for article (PubMed ID: 32779806)
1. A national study on prescribed medicine use in Australia on a typical day.
Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1046-1053. PubMed ID: 32779806
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy among older Australians, 2006-2017: a population-based study.
Page AT; Falster MO; Litchfield M; Pearson SA; Etherton-Beer C
Med J Aust; 2019 Jul; 211(2):71-75. PubMed ID: 31219179
[TBL] [Abstract][Full Text] [Related]
3. A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia.
Schaffer AL; Chia J; Brett J; Pearson SA; Falster MO
Pharmacotherapy; 2022 Nov; 42(11):828-836. PubMed ID: 36239072
[TBL] [Abstract][Full Text] [Related]
4. Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012.
Harris C; Daniels B; Ward RL; Pearson SA
Public Health Res Pract; 2017 Dec; 27(5):. PubMed ID: 31044212
[TBL] [Abstract][Full Text] [Related]
5. Potentially suboptimal prescribing of medicines for older Aboriginal Australians in remote areas.
Page A; Hyde Z; Smith K; Etherton-Beer C; Atkinson DN; Flicker L; Skeaf L; Malay R; LoGiudice DC
Med J Aust; 2019 Aug; 211(3):119-125. PubMed ID: 31187902
[TBL] [Abstract][Full Text] [Related]
6. Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia.
Falster MO; Charrier R; Pearson SA; Buckley NA; Daniels B
Br J Clin Pharmacol; 2021 Mar; 87(3):1264-1274. PubMed ID: 32737910
[TBL] [Abstract][Full Text] [Related]
7. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
[TBL] [Abstract][Full Text] [Related]
8. Learning from an epidemiological, population-based study on prescribed medicine use in adults.
Eckert KA; Shi Z; Taylor AW; Wittert G; Price K; Goldney RD
Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):271-7. PubMed ID: 23335093
[TBL] [Abstract][Full Text] [Related]
9. Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).
Pearson SA; Pesa N; Langton JM; Drew A; Faedo M; Robertson J
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):447-55. PubMed ID: 25833702
[TBL] [Abstract][Full Text] [Related]
10. Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia.
Lin J; de Oliveira Costa J; Pearson SA; Buckley NA; Brieger D; Schutte AE; Schaffer AL; Falster MO
J Hypertens; 2024 Jul; 42(7):1248-1255. PubMed ID: 38704239
[TBL] [Abstract][Full Text] [Related]
11. Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics.
Karanges EA; Buckley NA; Brett J; Blanch B; Litchfield M; Degenhardt L; Pearson SA
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):504-512. PubMed ID: 29280224
[TBL] [Abstract][Full Text] [Related]
12. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
[TBL] [Abstract][Full Text] [Related]
13. The changing face of Australian data reforms: impact on pharmacoepidemiology research.
de Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA
Int J Popul Data Sci; 2021 Apr; 6(1):1418. PubMed ID: 34007904
[TBL] [Abstract][Full Text] [Related]
14. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
[TBL] [Abstract][Full Text] [Related]
15. Use of prescription medicines in Australian women of child-bearing age.
Gadzhanova S; Roughead E
BMC Pharmacol Toxicol; 2015 Dec; 16():33. PubMed ID: 26643036
[TBL] [Abstract][Full Text] [Related]
16. The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020-21: an interrupted time series analysis.
Koch FC; Olivier J; Brett J; Buckley NA; Gisev N; Pearson S; Daniels B
Med J Aust; 2024 Apr; 220(6):315-322. PubMed ID: 38522006
[TBL] [Abstract][Full Text] [Related]
17. Dispensing patterns of emergency medicines prescribed by Australian dentists from 1992 to 2018 - a pharmacoepidemiology study.
Park JS; Kruger E; Tennant M
Int Dent J; 2020 Aug; 70(4):254-258. PubMed ID: 32170731
[TBL] [Abstract][Full Text] [Related]
18. Use of prescription drugs in the older adult population-a nationwide pharmacoepidemiological study.
Christensen LD; Reilev M; Juul-Larsen HG; Jørgensen LM; Kaae S; Andersen O; Pottegård A; Petersen J
Eur J Clin Pharmacol; 2019 Aug; 75(8):1125-1133. PubMed ID: 30949726
[TBL] [Abstract][Full Text] [Related]
19. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data.
Park HY; Ryu HN; Shim MK; Sohn HS; Kwon JW
Int J Clin Pharmacol Ther; 2016 May; 54(5):369-77. PubMed ID: 27007996
[TBL] [Abstract][Full Text] [Related]
20. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.
Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R
Intern Med J; 2016 Aug; 46(8):955-63. PubMed ID: 26602489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
